Edap Tms S.A. (NASDAQ:EDAP – Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 164,600 shares, an increase of 141.3% from the August 15th total of 68,200 shares. Based on an average trading volume of 90,500 shares, the short-interest ratio is currently 1.8 days. Currently, 0.4% of the shares of the stock are short sold. Currently, 0.4% of the shares of the stock are short sold. Based on an average trading volume of 90,500 shares, the short-interest ratio is currently 1.8 days.
Edap Tms Price Performance
Shares of Edap Tms stock traded down $0.17 on Monday, reaching $2.29. 41,200 shares of the stock were exchanged, compared to its average volume of 89,848. The firm’s 50 day moving average is $1.69 and its 200-day moving average is $1.83. Edap Tms has a one year low of $1.21 and a one year high of $3.27. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.05 and a current ratio of 1.51. The firm has a market cap of $85.44 million, a PE ratio of -3.73 and a beta of -0.21.
Hedge Funds Weigh In On Edap Tms
Institutional investors have recently added to or reduced their stakes in the stock. Millennium Management LLC increased its position in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 33,558 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 25,650 shares during the last quarter. Scoggin Management LP bought a new stake in Edap Tms during the 1st quarter worth approximately $686,000. Banque Transatlantique SA grew its holdings in Edap Tms by 7,063.7% during the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock worth $1,324,000 after acquiring an additional 720,499 shares during the last quarter. Finally, Cetera Investment Advisers grew its holdings in Edap Tms by 33.9% during the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider’s stock worth $147,000 after acquiring an additional 19,000 shares during the last quarter. 62.74% of the stock is currently owned by institutional investors and hedge funds.
About Edap Tms
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Featured Articles
- Five stocks we like better than Edap Tms
- 3 REITs to Buy and Hold for the Long Term
- 3 Hot Tech Stocks With Bullish Charts and Ample Upside
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Biotech Sector May Flip to Market Leader by Year-End
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Stocks Positioned to Win With Strong Recurring Revenue Streams
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.